how big is Genus Prime?

As of Jun 06, Genus Prime Infra Ltd has a market capitalization of 44.00 Cr, classifying it as a Micro Cap company, with recent net sales of 0.23 Cr and a net profit of -0.04 Cr. Shareholder's funds are 48.23 Cr, and total assets are valued at 69.57 Cr.

Market Cap: As of Jun 06, Genus Prime Infra Ltd has a market capitalization of 44.00 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 0.23 Cr, and the sum of Net Profit is -0.04 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is also on a Consolidated basis for the latest annual period ending in Mar'24. Shareholder's Funds are reported at 48.23 Cr, and Total Assets are valued at 69.57 Cr.

When is the next results date for Genus Prime?

No Upcoming Board Meetings

Who are in the management team of Genus Prime?

As of March 2022, the management team of Genus Prime includes Amit Agarwal (Whole Time Director & CEO), Simpal Agarwal (Director), and independent directors Dharam Chand Agarwal, Kamal Kant Agarwal, and Udit Agarwal.

As of March 2022, the management team of Genus Prime includes the following individuals:<BR><BR>1. Dharam Chand Agarwal - Independent Director<BR>2. Kamal Kant Agarwal - Independent Director<BR>3. Amit Agarwal - Whole Time Director & CEO<BR>4. Simpal Agarwal - Director<BR>5. Udit Agarwal - Independent Director<BR><BR>These members play various roles within the company's governance and management structure.

What does Genus Prime do?

Genus Prime Infra Ltd focuses on real estate development and operates within the commodity chemicals industry. As of March 2025, it reported net sales and net profit of 0 Cr, with a market cap of Rs 41 Cr.

Overview:<BR>Genus Prime Infra Ltd operates in the real estate development sector and belongs to the commodity chemicals industry within the micro-cap market.<BR><BR>History:<BR>The company was incorporated in 2000 and was formerly known as Gulshan Chemfill Ltd. It currently does not own any manufacturing facilities and has shifted its focus to real estate development as its main business. The latest quarterly results reported net sales and net profit of 0 Cr for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 0 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 0 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: Rs 41 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A (Loss Making)<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.47<BR>- Return on Equity: -0.09%<BR>- Price to Book: 0.93<BR><BR>Contact Details:<BR>Address: Near Moradabad Dharam Kanta, Kanth Road Harthala Moradabad Muzaffarnagar Uttar Pradesh : 244001<BR>Tel: 91-591-2511171<BR>Email: cs.genusprime@gamil.com<BR>Website: http://www.genusprime.com

Has Genus Prime declared dividend?

No Dividend History Available

Who are the peers of the Genus Prime?

Genus Prime's peers include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Haryana Leather, Ritesh Intl., Deco-Mica, and Sonal Adhesives. India Glycols leads in 1-year returns at 150.46%, while Genus Prime's return is 62.22%, and several peers have negative six-month returns.

Peers: The peers of Genus Prime are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Haryana Leather, Ritesh Intl., Deco-Mica, and Sonal Adhesives.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar and Fischer Medical, and the rest have Average management risk. Below Average growth is noted at Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Haryana Leather, Deco-Mica, and Sonal Adhesives, while Ritesh Intl. shows Good growth, and the rest have Average growth. Average capital structure is seen at Tata Chemicals, India Glycols, Ritesh Intl., and the rest have Below Average capital structure, except for GHCL which has Excellent capital structure.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.46%, while Deco-Mica has the lowest at -15.55%. Genus Prime's 1-year return of 62.22% is significantly higher than Deco-Mica's but lower than India Glycols'. Additionally, Tata Chemicals, Chemplast Sanmar, Haryana Leather, Deco-Mica, and Sonal Adhesives all have negative six-month returns.

What is the technical trend for Genus Prime?

As of May 26, 2025, Genus Prime's technical trend is mildly bullish, supported by daily moving averages and Bollinger Bands, despite some caution from weekly and monthly MACD and KST indicators.

As of 26 May 2025, the technical trend for Genus Prime has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD and KST are both mildly bearish, suggesting some caution. However, the Bollinger Bands on both weekly and monthly time frames are bullish, supporting the overall mildly bullish trend. The Dow Theory shows a mildly bullish signal on the weekly chart but no trend on the monthly. Despite recent underperformance in the weekly return compared to the Sensex, the longer-term returns are significantly strong, particularly over 3, 5, and 10 years. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and Bollinger Bands.

Who are the top shareholders of the Genus Prime?

The top shareholder of Genus Prime is promoter Rajendra Agarwal, holding 29.26%. Other notable shareholders include Arham Vyapaar Private Limited at 3.57% and individual investors with a collective 18.66%.

The top shareholders of Genus Prime include Rajendra Agarwal, who is the promoter with the highest holding at 29.26%. The company does not have any pledged promoter holdings, and there are no mutual funds or foreign institutional investors holding shares. The highest public shareholder is Arham Vyapaar Private Limited, which holds 3.57%. Additionally, individual investors collectively hold 18.66% of the shares.

How has been the historical performance of Genus Prime?

Genus Prime has consistently reported low net sales and negative profitability, with stable sales figures around 0.22 Cr but significant losses, particularly in Mar'24. The company faces ongoing financial challenges, reflected in negative profit margins and declining reserves.

Answer:<BR>The historical performance of Genus Prime shows a consistent trend of low net sales and negative profitability over the years.<BR><BR>Breakdown:<BR>Genus Prime's net sales have remained relatively stable, with figures of 0.22 Cr in Mar'25, Mar'23, and Mar'22, while slightly decreasing from 0.23 Cr in Mar'24 and Mar'20. The total operating income mirrored this trend, remaining at 0.22 Cr for Mar'25, Mar'23, and Mar'22. However, the company's total expenditure saw a significant spike in Mar'24 to 2.23 Cr, leading to an operating profit of -2.00 Cr, which improved to -0.04 Cr in Mar'25. The profit before tax followed a similar pattern, with a loss of -2.00 Cr in Mar'24 and a reduced loss of -0.04 Cr in Mar'25. The profit after tax also reflected these losses, with -2.00 Cr in Mar'24 and -0.04 Cr in Mar'25. The company's total liabilities decreased from 69.57 Cr in Mar'24 to 66.83 Cr in Mar'25, while total assets also declined from 69.57 Cr to 66.83 Cr in the same period. Cash flow from operating activities was non-existent in recent years, indicating challenges in generating cash from core operations. Overall, Genus Prime has faced ongoing financial difficulties, reflected in its negative profit margins and declining reserves.

Is Genus Prime overvalued or undervalued?

As of November 17, 2025, Genus Prime is considered very expensive and overvalued, with a PE ratio of 75.33 and an EV to EBITDA of 43.64, significantly higher than its peers, and has experienced an 18.60% year-to-date decline compared to an 8.72% rise in the Sensex.

As of 17 November 2025, the valuation grade for Genus Prime has moved from risky to very expensive. This indicates a significant shift in perception regarding the company's valuation, suggesting that it is currently overvalued. The company’s PE ratio stands at an exceptionally high 75.33, while its EV to EBITDA ratio is 43.64, both of which are considerably above industry norms. Additionally, the PEG ratio is a mere 0.02, indicating that the stock is priced excessively relative to its growth potential.<BR><BR>In comparison to its peers, Genus Prime's valuation metrics are starkly higher than those of Godrej Industries, which has a PE ratio of 37.63 and an EV to EBITDA of 40.96, making it appear relatively more attractive. Other peers, such as Gujarat Fluoroch, also show lower valuations with a PE of 57.85 and an EV to EBITDA of 31.25. Given these ratios and the overall market context, Genus Prime is deemed overvalued. Despite a strong historical performance over the long term, recent returns indicate a decline, with a year-to-date drop of 18.60% compared to an 8.72% rise in the Sensex, reinforcing the concerns about its current valuation.

Should I buy, sell or hold Genus Prime?

Why is Genus Prime falling/rising?

As of 03-Dec, Genus Prime Infra Ltd's stock price is at 23.31, down 3.72%, and underperformed its sector by 2.43%. The stock has a year-to-date decline of 16.45%, indicating it is lagging behind broader market indices despite increased investor participation.

As of 03-Dec, Genus Prime Infra Ltd's stock price is falling, currently at 23.31, which reflects a decrease of 0.9 or 3.72%. This decline is evident in the stock's performance today, where it underperformed its sector by 2.43%. Despite a significant increase in investor participation, with delivery volume rising by 1876.85% against the 5-day average, the stock remains lower than its 100-day and 200-day moving averages, indicating a potential lack of sustained upward momentum. <BR><BR>In terms of longer-term performance, the stock has experienced a year-to-date decline of 16.45%, contrasting sharply with the Sensex, which has gained 8.92% over the same period. This trend suggests that while there may be short-term fluctuations, the overall performance of Genus Prime Infra Ltd has not kept pace with broader market indices, contributing to the current downward pressure on its stock price.

Which are the latest news on Genus Prime?